Media

On June 16, the randomized controlled trial (RCT) research of Xiangshao Granules developed by Yangtze River Pharmaceutical Group (“YRPG” or “the Group”) was officially published in “Acta Pharmaceutica Sinica B”, a top international journal in pharmaceutical sciences. The paper is titled “A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Xiangshao Granules for Anxiety in Perimenopausal and Postmenopausal Women”. The journal boasts a latest Impact Factor of 14.6 and ran

To bolster local ecological protection and green sustainable development in Laos, Yangtze River Pharmaceutical Group (“YRPG” or "the Group") recently hosted a public welfare tree-planting event at the boat-fruited sterculia plantation base in Pakse, Champasak Province, Laos. Relevant officials and corporate representatives from China and Laos, alongside local residents, took part in the activity. Over 1,000 saplings of various varieties were planted on site. Through this joint ecological initia

From March 8 to 13, 2026, the International Forum on Quality and Safety in Healthcare was held in Oslo, Norway. Marking its 30th anniversary, the event was co-hosted by BMJ Group (BMJ) and the Institute for Healthcare Improvement (IHI), with support from the Norwegian Directorate of Health and other authorities, standing as a globally influential conference in healthcare quality and safety. At the invitation of BMJ, Gu Chengming, Marketing Director of Yangtze River Pharmaceutical Group (“YRPG” o

Approved via the EU Decentralised Procedure (DCP) led by the Netherlands with Germany as reference member state, filed in 2021, Guangzhou Hairui’s Parecoxib Sodium for Injection has recently obtained marketing authorization in Germany. Another key EU market access achieved. Every step forward reflects solid strength.Pressing ahead steadily! The Group’s global footprint for Parecoxib Sodium for Injection is rapidly expanding with clear results. To date, agreements cover over 20 countries; 9 (incl

Recently, the 27th World Meeting on Sexual Medicine ( “WMSM” or “the Meeting”) was held in Porto, Portugal. As a highly influential global academic event in the medical field, the congress brought together more than 1,200 experts and scholars from 41 countries, with a total of 940 academic abstracts accepted. The Class 1 innovative drug Tolonadaf Hydrochloride Tablets (brand name: Taituotuo®), independently developed by Yangtze River Pharmaceutical Group ( “YRPG” or “the Group” ), made its debut

Recently, the 15th Philanthropy Festival and 2025 ESG Summit were held in Beijing. Yangtze River Pharmaceutical Group Co., Ltd. ( “YRPG” or “the Group” ) was awarded both the "2025 Model Enterprise for Responsibility in Healthcare" and the "2025 ESG Case of the Year" in recognition of its long-term commitment and practical initiatives in healthcare responsibility and public welfare.The Philanthropy Festival, the country’s first festival themed “public welfare” and co-launched by mainstream publi

On December 17, a caring team from Yangtze River Pharmaceutical Group Co., Ltd. ( “YRPG” or “the Group” ), led by key executives Cai Wei and Tan Guangzhao arrived in Laos to launch the “Health for all, all for Health” initiative at Mahosot General Hospital in Vientiane. The team included representatives from Yangtze River Import and Export Co., Ltd., the Great Health Sector, Marketing Department, and Brand and Publicity Department. This health mission reflects the Group’s commitment to its corpo

On November 17th (local time), at the press center of the 30th Conference of the Parties to the United Nations Framework Convention on Climate Change (COP30) held in Belém, Brazil, the Publicity and Education Center of the Ministry of Ecology and Environment, together with the China Champions for Climate Action, held the launch event of 2025 Beautiful China · Green Space Users Case Collection (hereinafter referred to as the "Case Collection") . Among the 40 selected cases, Yangtze River Pharmace